Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Mikael Lantz, Region Skane
ClinicalTrials.gov Identifier:
NCT01458600
First received: October 19, 2011
Last updated: December 15, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2015
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)